CD274 and neoplasm: Studies have shown that PD-L1 is expressed in 30–65% invasive GCs and is related to the depth of tumor invasion, lymph node metastasis, distant metastasis, tumor size, EBV infection, etc., which is a negative marker of prognosis (60–62).